Abstract:Background: Antimicrobial peptides play an important role in the innate immune system. Possessing broad-spectrum antibacterial activity, antimicrobial peptides can quickly treat and kill various targets, including gram-negative bacteria, gram-positive bacteria, fungi, and tumor cells. Objective: An overview of the state of play with regard to the research trend of antimicrobial peptides in recent years and the situation of targeting tumor cells, and to make statistical analysis of the patents related to anticancer peptides published in recent years, is important both from toxicological and medical tumor therapy point of view. Methods: Based on the Science Citation Index Expanded version, the Derwent Innovation Index and Innography as data sources, the relevant literature and patents concerning antimicrobial peptides and anticancer peptides were analyzed through the Thomson Data Analyzer. Results of toxicologic and pharmacologic studies that brought to the development of patents for methods to novel tumor drugs were analyzed and sub-divided according to the specific synthesis of anticancer peptides. Results: The literature and patent search data show that the research and development of global antimicrobial peptides and anticancer peptides has been in an incremental mode. Growing patent evidence indicate that bioinformatics technology is a valuable strategy to modify, synthesize or recombine existing antimicrobial peptides to obtain tumor drugs with high activity, low toxicity and multiple targets. Conclusion: These findings may have important clinical implications for cancer treatment, especially in patients with conditions that are not currently treatable by other drugs, or that are resistant to existing cancer drugs.

Tachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential

Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics

From Antimicrobial to Anticancer Peptides: The Transformation of Peptides.

Antitumor mechanisms and future clinical applications of the natural product triptolide

Research Progress on Antitumor Effects of Antimicrobial Peptides

Application Value of Antimicrobial Peptides in Gastrointestinal Tumors

Bacteriocins in Cancer Treatment: Mechanisms and Clinical Potentials

Harnessing Bacteria for Tumor Therapy: Current Advances and Challenges

Protein-protein interaction: a novel direction for discovering anti-tumor drugs

The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties

Awareness of intratumoral bacteria and their potential application in cancer treatment

Potential antitumor activity of triptolide and its derivatives: Focused on gynecological and breast cancers

A Review for Antimicrobial Peptides with Anticancer Properties: Re-purposing of Potential Anticancer Agents

Synthesis and Biological Evaluation of Novel Peptides Based on Antimicrobial Peptides As Potential Agents with Antitumor and Multidrug Resistance-Reversing Activities

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Bacterial Proteins and Peptides as Potential Anticancer Agents: A Novel Search for Protein-based Therapeutics

Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era

Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context

Systematic review on the role of the gut microbiota in tumors and their treatment

Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate - An example of breast cancer

Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria